Nat. Rev. Endocrinol. doi: /nrendo

Slides:

Advertisements

Similar presentations

(Adapted, with permission, from Fagin JA

Advertisements

Fig. 1. Correlation of TSH with TC, LDL-C, HDL-C, and TG.

Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447

Nat. Rev. Endocrinol. doi: /nrendo

Invest. Ophthalmol. Vis. Sci ;55(3): doi: /iovs Figure Legend:

Copyright © 2017 American Academy of Pediatrics.

Nat. Rev. Cardiol. doi: /nrcardio

HT (n = 45), healthy control subjects (HC) (n = 22), DTC-I, recurrent or persistent DTC (n = 27), DTC-II, disease free DTC (n = 34). Tg clusters are defined.

Figure 1. Total (A) and free (B) T, estradiol (C), and SHBG (D) levels at baseline and during treatment. From: Testosterone Treatment and Sexual Function.

Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.

FIG. 1 Odds ratios (95% CIs) of metabolic syndrome and individual components calculated for clinical measures of periodontal disease (A and B). For gingival.

From: Is Age a Risk Factor for Hypothyroidism in Pregnancy

Figure 2 Electromechanical properties of OIHPs

Figure 6 Selected examples of TERS applications in material systems

Figure 1. Correlations between TNFα and HOMA IR in men (•) and women (○). Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population.

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 2 Regions of Africa exposed to undernutrition

with undiagnosed diabetes mellitus by three diagnostic criteria

Nat. Rev. Endocrinol. doi: /nrendo

Figure 5 BMI and cardiorespiratory fitness levels

Nat. Rev. Nephrol. doi: /nrneph

Figure 4 BMI and mortality in patients with heart failure

Figure 5 MRI of childhood craniopharyngioma

Figure 2 Bad-metal behaviour and electron correlations

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Circadian and ultradian fluctuations in corticosterone

Figure 2 Expression of complement activation products in renal samples

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 CAR-T-cell design

Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Osteosarcoma epidemiology

Figure 3 Prediction of superconductivity in FeB4

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Challenges and opportunities of using omics in EDC research

Figure 1 Oestrogen biosynthesis and production sites in the body

Figure 3 Satiety, bacterial growth and satiety hormone release

Nat. Rev. Endocrinol. doi: /nrendo

Figure 4 Tracheal endoscopy in two patients

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Serum levels of TSH and free T4 in a large series

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Figure 1 Cardiovascular risk and disease across the life-course

Figure 3 Clinical trial design in charged-particle therapy (CPT)

Nat. Rev. Endocrinol. doi: /nrendo

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Nephrol. doi: /nrneph

Part a is adapted from Gilmore, J. H. et al

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Regulation of hepatic glucose metabolism by the gut, brain and liver Figure 1 | Regulation of hepatic glucose metabolism by the gut, brain and.

Figure 3 Serum phosphate level is associated with

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Exosomes mediate the systemic benefits of endurance exercise

Figure 7 Corneal tissue engineering

Figure 1 Oxidative phosphorylation

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Radiogenomics analysis can reveal relationships

Figure 1 Timeline of pancreatic islet transplantation

3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 Determination of the primary site

Figure 3 Global iodine status and mandatory salt iodization

Increasing prevalence of multidrug resistance among P

Nat. Rev. Endocrinol. doi: /nrendo

Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.226 Figure 1 Identification of CD34+ fibrocytes in patients with Graves disease and TAO Adapted with minor modifications with permission of Endocrine Society from Douglas, S. et al. Increased generation of fibrocytes in thyroid-associated ophthalmopathy, J. Clin. Endocrinol. Metab. 95, ©2010; permission conveyed through Copyright Clearance Center, Inc. Smith, T. J. (2014) TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy Nat. Rev. Endocrinol. doi:10.1038/nrendo.2014.226